Li-Anne Rowswell Mufson Li-Anne Rowswell Mufson

Digital Twins and AI-Driven Drug Discovery

This week in the Guardrail, we break down how predictive AI models and clinical digital twins are accelerating time to market, streamlining regulatory filings, and reshaping early-phase trial architecture.

Read More
AI Amanda Sicard AI Amanda Sicard

How AI Is Reducing Drug Development Timelines From Years to Months

Today, artificial intelligence (AI) is changing this story. With the help of AI, scientists and companies are finding ways to shrink drug development timelines from years to months. Reshaping the pharmaceutical industry can accelerate drug development, improve efficiency, and potentially increase the success of projects.

Read More